EyeNet - American Academy of Ophthalmology

Shop

Advertisement
EyeNet Magazine /

Latest Issue

November 2019
Download PDF

Private Equity and Ophthalmology

From choppy regulatory waters to rapidly increasing costs, there are many reasons to ponder your economic future. Should you stay the course? Consolidate your practice with others? Or seek a deal with private equity? This month’s feature takes a look.

The November supplement from MedEdicus can be found here: Real-World Management of Glaucoma—The Age of Outflow.

Ophthalmic Pearls

Familial Exudative Vitreoretinopathy

By Sri Meghana Konda, MBBS, Randy C. Bowen, MD, MS, Jonathan S. Chang, MD, and Mihai Mititelu, MD, MPH
Edited By: Ingrid U. Scott, MD, MPH, and Bennie H. Jeng, MD

First, understand the differential for this often-misdiagnosed disease, then treat. Web Extra: Two case studies.

Comments 0

Views 3580

Clinical Update

MD Roundtable, Part 2: Selecting the Right MIGS

By Ahmad A. Aref, MD, MBA, with Albert S. Khouri, MD, and Constance O. Okeke, MD, MSCE

In Part 2 of a roundtable, three experts discuss MIGS modalities in various hypothetical cases.

Comments 0

Views 833

Diabetic Retinopathy Tx: A Role for Fibrates and Statins?

By Annie Stuart, Contributing Writer, interviewing Emily Y. Chew, MD, Sunir J. Garg, MD, and Eugene Yu-Chuan Kang, MD

Do statins have a role to play in treating diabetic retinopathy? An update.

Comments 0

Views 1458

Morning Rounds

A Case of Fever and Floaters

By Akshaya Gupta, Lance Lyons, MD, and Larry Puthenparambil, MD
Edited By: Steven J. Gedde, MD

After developing fever, sore throat, and malaise, the 62-year-old was assumed to have cat-scratch disease—but a course of azithromycin did her no good.

Comments 0

Views 1901

Blink

Can You Guess November's Mystery Condition?

Make your diagnosis in the comments, and get the answer to last month’s mystery.

Comments 0

Views 2665

Journal Highlights

Retinal Changes Preceding Diabetic Retinopathy, High Costs of Rx Waste, and More

Our editors summarize the most exciting studies from Ophthalmology, Ophthalmology Retina, American Journal of Ophthalmology, JAMA Ophthalmology, and other journals.

Comments 0

Views 0

News in Review

CyPass Update: IOP Effect Seen, Cell Loss Noted

The latest on CyPass safety.

Comments 0

Views 427

Genetic Dx in Kids: Knowledge Needed

What do you know about genetics?

Comments 0

Views 0

Visual Signs May Herald Parkinson Disease

Visual abnormalities among the most frequent nonmotor symptoms in the early stages of Parkinson disease.

Comments 0

Views 0

FLIO May Help in Screening for HCQ Toxicity

Can a novel imaging technology reveal retinal damage earlier than currently available modalities?

Comments 0

Views 743

Academy Notebook

News, Tips, Resources

A benchmarking tool for clinicians comes to the IRIS Registry. Mark your calendar for Giving Tuesday. And more.

Comments 0

Views 0

Practice Perfect

Considering a Private Equity Deal? Due Diligence Is Crucial

By Lori Baker-Schena, MBA, EdD, interviewing Mark D. Abruzzo, JD, Dustin C. Carter, Kimberly A. Drenser, MD, PhD, and Gary I. Markowitz, MD

Thorough due diligence is crucial—enlist the help of experts and be ready for a marathon.

Comments 0

Views 580

Savvy Coder

E&M or Eye Visit Code? What Level?

By Kristin Carter, MD, and Sue Vicchrilli, COT, OCS, OCSR, Academy Director of Coding and Reimbursement

What level of exam does the documentation support? Web Extra: the chart for Exam 2—An established patient complained of morning crusting on her eyelids and a burning sensation.

Comments 0

Views 1371

Opinion

#ThisIsMyLane

Ruth D. Williams, MD, Chief Medical Editor, on tackling gun violence as a public health issue.

Comments 0

Views 365

Private Equity and Ophthalmology

Ophthalmic Pearls

Clinical Update

Morning Rounds

Blink

Journal Highlights

News in Review

Academy Notebook

Practice Perfect

Savvy Coder

Opinion

OUR SITES

FOLLOW THE ACADEMY